Low-dose vaginal estrogens, available in various applications such as creams, tablets, inserts, and rings, are the mainstay of GSM treatment.

If you're experiencing vaginal discomfort during menopause, you're far from alone-up to 84 percent of postmenopausal women deal with the issue, according to a study in Menopause. In fact, the changes ...

Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, ...

The AMPLITUDE trial showed Zejula's efficacy in extending progression-free survival in metastatic hormone-sensitive prostate cancer with HRR gene defects. Achieving a PSA level below 0.2 in prostate ...

Please provide your email address to receive an email when new articles are posted on . Genitourinary syndrome of menopause is common but often underrecognized in dermatology. Low-dose vaginal ...

Universal testing for pathogenic germline variants in patients with genitourinary cancers identifies potentially actionable variants that may be missed with guideline-based testing, new research ...

From fatigue to neuropathy, managing treatment-related side effects is central to improving quality of life in breast cancer.

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, announced today that its PROSTOX ultra test is now available for ordering in the United States. The ...

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including three accepted ...

SAN FRANCISCO—Genitourinary tuberculosis (GUTB) cases are on the rise in the United States and globally, but they often are difficult to diagnose, leading to a delay in dialysis that can worsen renal ...